Neumora Therapeutics Inc (NMRA) Implied Volatility Current

Tracking NMRA implied volatility helps you identify when options premiums on Neumora Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Neumora Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when NMRA IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Neumora Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For NMRA, tracking metrics like NMRA IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on NMRA signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in phase 1 clinical trials in patients with agitation associated with dementia due to Alzheimer's disease; and NMRA-266, which is in the phase 1 clinical trial for the treatment of schizophrenia and other neuropsychiatric disorders.

In addition, its preclinical phase product includes NMRA-NMDA for the treatment of schizophrenia; NMRA-CK1d, a CK1d inhibitor program for the treatment of amyotrophic lateral sclerosis; NMRA-NLRP3 for the treatment of certain neurodegenerative conditions; and NMRA-GCase for the treatment of Parkinson's disease. The company was formerly known as RBNC Therapeutics, Inc. and changed its name to Neumora Therapeutics, Inc. in October 2021. Neumora Therapeutics, Inc. was incorporated in 2019 and is headquartered in Watertown, Massachusetts.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where NMRA implied volatility sits today versus where it has been. Our scanner ranks Neumora Therapeutics Inc implied volatility against its historical range, surfaces extremes in NMRA IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Neumora Therapeutics Inc IV is rich or cheap — measure it, then act on it.